Recombinant TYMS anticorps (AA 1-200)
Aperçu rapide pour Recombinant TYMS anticorps (AA 1-200) (ABIN7868768)
Antigène
Voir toutes TYMS AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- AA 1-200
-
Fonction
- Recombinant Thymidylate Synthase Antibody / TYMS (azide and preservative free)
-
Purification
- Protein A/G affinity
-
Immunogène
- A recombinant human thymidylate synthase protein fragment (within amino acids 1-200) was used as the immunogen for the recombinant Thymidylate Synthase antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the recombinant Thymidylate Synthase antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the recombinant Thymidylate Synthase antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- TYMS (Thymidylate Synthetase (TYMS))
-
Autre désignation
- Thymidylate Synthase
-
Sujet
- It recognizes a protein of 36 kDa, identified as Thymidylate Synthase (TS) (EC 2.1.1.45). It converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is essential for DNA biosynthesis. TS is also a critical target for the fluoropyrimidines, an important group of antineoplastic drugs that are widely used in the treatment of solid tumors. Both 5-FU and fluorodeoxyuridine are converted in tumor cells to FdUMP which inactivates TS by formation of a ternary covalent complex in the presence of the folate cofactor 5,10-methylenetetrahydrofolate. Expression of TS protein has been reported to associate with response to 5-fluorouracil (5-FU) in human colorectal, gastric, head and neck, and breast carcinomas.
-
UniProt
- P04818
-
Pathways
- Mitotic G1-G1/S Phases
Antigène
-